CME

Dermatology CME/CE Courses

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

Signals of Change in the Management of Atopic Dermatitis

Signals of Change in the Management of Atopic Dermatitis | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s)
This CMEO webcast blends faculty presentation and discussion to assist learners in applying clinical tools to establish disease severity, translating how new agents will impact clinical practice, and integrating patient preferences and treatment goals into shared decision-making (SDM).
What Does the Future Hold in the Treatment of Atopic Dermatitis?

What Does the Future Hold in the Treatment of Atopic Dermatitis?

AMA PRA Category 1 Credit(s)TM, AANP Contact Hour(s)
Part of the National Eczema Association’s Coalition United for Better Eczema Care (CUBE-C) educational series, this activity will the impact AD has on a patient’s QOL, as well as current and emerging agents for the treatment of AD.
Hitting the Target with IL-23 Inhibitors in Psoriatic Arthritis

Hitting the Target with IL-23 Inhibitors in Psoriatic Arthritis | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s)
In this CME Outfitters Live and OnDemand activity, expert faculty will focus on assessment, treatment, and management strategies to provide patients with the best treatment aligned with evolving evidence and expert recommendations.
The Management of Common AD-Related Comorbidities

The Management of Common AD-Related Comorbidities

AMA PRA Category 1 Credit(s)TM
In this case-based activity, two physician experts in the management of AD are joined by a longtime patient with AD to discuss some of the most significant challenges patients with AD and comorbidities face on a day-to-day basis.
JAK/TYK2 Inhibition: New Frontiers in the Treatment of Psoriasis

JAK/TYK2 Inhibition: New Frontiers in the Treatment of Psoriasis | myCME

AMA PRA Category 1 Credit(s)TM
This activity will provide clinicians with a solid foundation for understanding the pathophysiology of psoriasis along with other autoimmune diseases, how this pathophysiology informs treatment options, and the most recent clinical trial data for current and emerging agents and management recommendations available to guide therapy selection.

Click for More Dermatology Courses

Next hm-section-front in CME